Literature DB >> 4018082

Differentiation of rat myoblasts. Regulation of turnover of ribosomal proteins and their mRNAs.

F A Jacobs, R C Bird, B H Sells.   

Abstract

The regulation of ribosomal proteins (r-proteins) and their mRNAs (rp-mRNAs) was studied in the L6 myoblast, a mammalian cell line which can undergo myogenesis. Upon terminal differentiation, the rate of accumulation of mature ribosomes dropped to approximately 25% of the rate found in undifferentiated myoblasts. Despite the drop in the rate of ribosome accumulation and the rate of rRNA synthesis following terminal differentiation, the rate of r-protein synthesis remained constant. The excess r-protein synthesized in myotubes was quickly degraded. The levels of rp-mRNAs were assessed before and after differentiation. Over 90% of the rp-mRNAs were found on polysomes in both myoblasts and myotubes and represented similar fractions of total poly(A)-rich mRNA. The half-lives of the rp-mRNAs averaged approximately 11 h in both myoblasts and myotubes. In vitro nuclear transcription measurements of a representative rp-mRNA (L32 mRNA) revealed that following differentiation, its rate of synthesis relative to the overall transcription rate dropped by approximately 26% in myotubes while the rate of transcription of rRNA dropped by approximately 77%. These results indicate that the coordination of r-protein and rRNA synthesis observed in myoblasts was uncoupled in myotubes at the level of transcription.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018082     DOI: 10.1111/j.1432-1033.1985.tb09015.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

1.  Selective translational control and nonspecific posttranscriptional regulation of ribosomal protein gene expression during development and regeneration of rat liver.

Authors:  R Aloni; D Peleg; O Meyuhas
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

Review 2.  Regulation of ribosome biogenesis in differentiated rat myotubes.

Authors:  P Zahradka; D E Larson; B H Sells
Journal:  Mol Cell Biochem       Date:  1991 May 29-Jun 12       Impact factor: 3.396

3.  Proto-oncogene expression in proliferating and differentiating cardiac and skeletal muscle.

Authors:  W C Claycomb; N A Lanson
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

4.  Translational initiation factor expression and ribosomal protein gene expression are repressed coordinately but by different mechanisms in murine lymphosarcoma cells treated with glucocorticoids.

Authors:  S Huang; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

5.  The synthesis of ribosomal proteins S16 and L32 is not autogenously regulated during mouse myoblast differentiation.

Authors:  L H Bowman
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

6.  Glucocorticoids selectively inhibit translation of ribosomal protein mRNAs in P1798 lymphosarcoma cells.

Authors:  O Meyuhas; E A Thompson; R P Perry
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

7.  A unique subspecies of histone H4 mRNA from rat myoblasts contains poly(A).

Authors:  R C Bird; F A Jacobs; G Stein; J Stein; B H Sells
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Stimulation of ribosomal RNA synthesis during hypertrophic growth of cultured heart cells by phorbol ester.

Authors:  T Haneda; P J McDermott
Journal:  Mol Cell Biochem       Date:  1991 May 29-Jun 12       Impact factor: 3.396

9.  Ku80 is required but not sufficient for Galpha13-mediated endodermal differentiation in P19 embryonic carcinoma cells.

Authors:  Jyotshnabala Kanungo; Hsien-Yu Wang; Craig C Malbon
Journal:  Biochem Biophys Res Commun       Date:  2004-10-08       Impact factor: 3.575

10.  Coordinated decreases in rRNA gene transcription factors and rRNA synthesis during muscle cell differentiation.

Authors:  D E Larson; W Xie; M Glibetic; D O'Mahony; B H Sells; L I Rothblum
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.